Targeted RFA 2018 Review Panel

Review Panel for Movember Translation Acceleration Grant to Validate Predictive Markers for Treatment Response and Outcome

A panel of experts will be assembled to review the applications submitted to this competition:
Bill Watson, Chair UCD School of Medicine
Conway Institute of Biomolecular and Biomedical Research
University College Dublin
Dublin, Ireland
Christopher Barbieri Weill Cornell Medicine
New York, NY, USA
Adam Dicker Jefferson Medical College of Thomas Jefferson University
Philadelphia, PA, USA
Robert Jeraj University of Wisconsin School of Medicine and Public Health
Madison, WI, USA
Glen Kristiansen University Hospital Bonn
Bonn, Germany
Lorelei Mucci Harvard T.H. Chan School of Public Health
Dana-Farber/Harvard Cancer Center
Boston, MA, USA
Joachim Weischenfeldt Biotech Research & Innovation Centre (BRIC)
University of Copenhagen
Copenhagen, Denmark
Catharine West The University of Manchester
Manchester, UK
Hayley Whitaker University College London
London, UK
John Ronald, Scientific Officer Robarts Research Institute
London, ON
Karla Williams, Scientific Officer University of British Columbia
Vancouver, BC
Thomas Flannery, Community Representative Toronto, ON
Neil Palmer, Community Representative Ottawa, ON
Additional panel members will be added as they are confirmed.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive